Polyamines in cardiac physiology and disease

Open Heart Failure Journal

Volumn 3, Issue SPEC. ISS.1, 2010, Pages 25-30

  Giordano, Emanuele ^a   Flamigni, Flavio ^a   Guarnieri, Carlo ^a   Muscari, Claudio ^a   Pignatti, Carla ^a   Stefanelli, Claudio ^a   Tantini, Benedetta ^a   Caldarera, Claudio Marcello ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Cell growth; Differentiation; Heart hypertrophy; Polyamines

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; POLYAMINE; POLYCATION; PROTEIN BCL 2; PUTRESCINE; SPERMIDINE; SPERMINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; DISEASE COURSE; EMBRYO CULTURE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART DISEASE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; NONHUMAN; PATHOPHYSIOLOGY; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; WILD TYPE;

EID: 84858866760     PISSN: None     EISSN: 18765351     Source Type: Journal    
DOI: 10.2174/1876535101003020025     Document Type: Review

References (84)

1. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003; 376: 1-14.
2. Wang Y, Casero RA Jr. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem (Tokyo) 2006; 139: 17-25.
3. Mitchell JL, Thane TK, Sequeira JM, Thokala R. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy. Biochem Soc Trans 2007; 35: 318-21.
4. Kala P, Krausová P. A review of dietary polyamines: formation, implications for growth and health and occurrence in foods. Food Chem 2005; 90: 219-30.
5. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4: 781-92.
6. Bachrach U, Wang YC, Tabib A. Polyamines: new cues in cellular signal transduction. News Physiol Sci 2001; 16: 106-9.
7. Seiler N, Raul F. Polyamines and apoptosis. J Cell Mol Med 2005; 9: 623-42.
8. Pignatti C, Tantini B, Stefanelli C, Flamigni F. Signal transduction pathways linking polyamines to apoptosis. Amino Acids 2004; 27: 359-65.
9. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001; 58: 244-58.
10. Fan CC, Koenig H. The role of polyamines in beta-adrenergic stimulation of calcium influx and membrane transport in rat heart. J Mol Cell Cardiol 1988; 20: 789-99.
11. Bordallo C, Cantabrana B, Velasco L, et al. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat. Eur J Pharmacol 2008; 598: 68-74.
12. Koenig H, Fan CC, Goldstone AD, Lu CY, Trout JJ. Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ Res 1989; 64: 415-26.
13. Bordallo C, Rubin JM, Varona AB, Cantabrana B, Hidalgo A, Sanchez M. Increases in ornithine decarboxylase activity in the positive inotropism induced by androgens in isolated left atrium of the rat. Eur J Pharmacol 2001; 422: 101-7.
14. Velasco L, Secades L, Bordallo C, et al. Role of putrescine on androgen-elicited positive inotropism in the left atrium of rats. J Cardiovasc Pharmacol 2008; 52: 161-6.
15. Sánchez M, Secades L, Bordallo C, et al. Role of polyamines and cAMP-dependent mechanisms on 5alpha-dihydrotestosteroneelicited functional effects in isolated right atria of rat. J Cardiovasc Pharmacol 2009; 54(4): 310-8.
16. Caldarera CM, Casti A, Guarnieri C, Moruzzi G. Regulation of ribonucleic acid synthesis by polyamines. Reversal by spermine of inhibition by methylglyoxal bis(guanylhydrazone) of ribonucleic acid synthesis and histone acetylation in rabbit heart. Biochem J 1975; 152: 91-8.
17. Ventura C, Ferroni C, Flamigni F, Stefanelli C, Capogrossi MC. Polyamine effects on [Ca2+]i homeostasis and contractility in isolated rat ventricular cardiomyocytes. Am J Physiol 1994; 267: H587-92.
18. Harris SP, Patel JR, Marton LJ, Moss RL. Polyamines decrease Ca(2+) sensitivity of tension and increase rates of activation in skinned cardiac myocytes. Am J Physiol Heart Circ Physiol 2000; 279: H1383-91.
19. Wang R, Xu CQ, Zhao WM, et al. Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 2003; 270: 2680-8.
20. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
21. Hilfiker-Kleiner D, Landmesser U, Drexler H. Molecular mechanisms in heart failure. J Am Coll Cardiol 2006; 48: A56-66.
22. Hoshijima M, Chien KR. Mixed signals in heart failure: cancer rules. J Clin Invest 2002; 109: 849-55.
23. Oredsson SM. Polyamine dependence of normal cell-cycle progression. Biochem Soc Trans 2003; 31: 366-70.
24. Flamigni F, Rossoni C, Stefanelli C, Caldarera CM. Polyamine metabolism and function in the heart. J Mol Cell Cardiol 1986; 18: 3-11.
25. Pucéat M. Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases. Curr Opin Pharmacol 2008; 8: 189-92.
26. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 1996; 28: 1737-46.
27. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-7.
28. Pignatti C, Tantini B, Stefanelli C, et al. Nitric oxide mediates either proliferation or cell death in cardiomyocytes. Involvement of polyamines. Amino Acids 1999; 16: 181-90.
29. Tantini B, Pignatti C, Fattori M, et al. NF-kappaB and ERK cooperate to stimulate DNA synthesis by inducing ornithine decarboxylase and nitric oxide synthase in cardiomyocytes treated with TNF and LPS. FEBS Lett 2002; 512: 75-9.
30. Tantini B, Flamigni F, Pignatti C, et al. Polyamines, NO and cGMP mediate stimulation of DNA synthesis by tumor necrosis factor and lipopolysaccharide in chick embryo cardiomyocytes. Cardiovasc Res 2001; 49: 408-16.
31. Stabellini G, Brugnoli F, Calastrini C, et al. Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid. Biomed Pharmacother 2004; 58: 401-6.
32. Vuohelainen S, Pirinen E, Cerrada-Gimenez M, et al. Spermidine is indispensable in differentiation of 3T3-L1 fibroblasts to adipocytes. J Cell Mol Med 2009; DOI 10.1111/j.1582-4934.2009.00808.x
33. MacLean HE, Chiu WSM, Notini AJ, et al. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J 2008; 22: 2676-89.
34. Erwin BG, Ewton DZ, Florini JR, Pegg AE. Polyamine depletion inhibits the differentiation of L6 myoblast cells. Biochem Biophys Res Commun 1983; 114: 944-9.
35. Govoni M, Bonavita F, Shantz LM, Guarnieri G, Giordano E. Overexpression of ornithine decarboxylase increases myogenic potential of H9c2 rat myoblasts. Amino Acids 2010; 38(2): 541-7.
36. Nesselmann C, Ma N, Bieback K, et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med 2008; 12: 1795-810.
37. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-201.
38. Muscari C, Bonafé F, Stanic I, et al. Polyamine depletion reduces TNFalpha/MG132-induced apoptosis in bone marrow stromal cells. Stem Cells 2005; 23: 983-91.
39. Muscari C, Bonafé F, Carboni M, et al. Difluoromethylornithine stimulates early cardiac commitment of mesenchymal stem cells in a model of mixed culture with cardiomyocytes. J Cell Biochem 2008; 103: 1046-52.
40. García-Faroldi G, Correa-Fiz F, Abrighach H, et al. Polyamines affect histamine synthesis during early stages of IL-3-induced bone marrow cell differentiation. J Cell Biochem 2009; 108: 261-71.
41. Schipper RG, Penning LC, Verhofstad AA. Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors? Semin Cancer Biol 2000; 10: 55-68.
42. Takemura G, Fujiwara H. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 2006; 10: 56-75.
43. Kitsis RN, Mann DL. Apoptosis and the heart: a decade of progress. J Mol Cell Cardiol 2005; 38: 1-2.
44. van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovasc Res 2005; 67: 21-9.
45. Poulin R, Pelletier G, Pegg AE. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylaseoverproducing L1210 cells. Biochem J 1995; 311: 723-7.
46. Stefanelli C, Bonavita F, Stanic' I, et al. Spermine causes caspase activation in leukaemia cells. FEBS Lett 1998; 437: 233-6.
47. Erez O, Goldstaub D, Friedman J, Kahana C. Putrescine activates oxidative stress dependent apoptotic death in ornithine decarboxylase overproducing mouse myeloma cells. Exp Cell Res 2002; 281: 148-56.
48. Stefanelli C, Pignatti C, Tantini B, et al. Effect of polyamine depletion on caspase activation: a study with spermine synthase-deficient cells. Biochem J 2001; 355: 199-206.
49. Li L, Rao JN, Guo X, et al. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 2001; 281: C941-53.
50. Tantini B, Fiumana E, Cetrullo S, et al. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. J Mol Cell Cardiol 2006; 40: 775-82.
51. Han L, Xu C, Jiang C, et al. Effects of polyamines on apoptosis induced by simulated ischemia/reperfusion injury in cultured neonatal rat cardiomyocytes. Cell Biol Int 2007; 31:1345-52.
52. Zhao YJ, Xu CQ, Zhang WH, et al. Role of polyamines in myocardial ischemia/reperfusion injury and their interactions with nitric oxide. Eur J Pharmacol 2007; 562: 236-46.
53. Zhao YJ, Zhang WH, Xu CQ, et al. Involvement of the ornithine decarboxylase/polyamine system in precondition-induced cardioprotection through an interaction with PKC in rat hearts. Mol. Cell. Biochem 2009; 332(1-2): 135-44.
54. Bonavita F, Stefanelli C, Giordano E, et al. H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA. FEBS Lett 2003; 536: 85-91.
55. Flamigni F, Stanic' I, Facchini A, et al. Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells. Amino Acids 2007; 33: 197-202.
56. Stefanelli C, Pignatti C, Tantini B, et al. Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim Biophys Acta 1999; 1450: 406-13.
57. Pignatti C, Stefanelli C. Ischemia/reperfusion-induced apoptosis: connecting nitric oxide and cell cycle regulators. Cardiovasc Res 2003; 59: 268-70.
58. Ryu JH, Cho YS, Chun YS, Park JW. Myocardial SSAT induction via AMPK signaling and its implication for ischemic injury. Biochem Biophys Res Commun 2008; 366: 438-44.
59. Caldarera CM, Casti A, Rossoni C, Visioli O. Polyamines and noradrenaline following myocardial hypertrophy. J Mol Cell Cardiol 1971; 3: 121-6.
60. Bartolome JV, Guguenard J, Slotkin TA. Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 1980; 210: 793-4.
61. Pegg AE, Hibasami H. Polyamine metabolism during cardiac hypertrophy. Am J Physiol 1980; 239: E372-8.
62. Feldman MJ, Russel DH. Polyamine biogenesis in left ventricle of the rat heart after aortic constriction. Am J Physiol 1972; 222; 1199-203.
63. Russell DH, Shiverick KT, Hamrell BB, Alpert NR. Polyamine synthesis during initial phases of stress-induced cardiac hypertrophy. Am J Physiol 1971; 221: 1287-91.
64. Caldarera CM, Orlandini G, Casti A, Moruzzi G. Polyamine and nucleic acid metabolism in myocardial hypertrophy of the overloaded heart. J Mol Cell Cardiol 1974; 6: 95-103.
65. Rettig G, Gibson K, Harris P. Effects of propranolol on rat myocardial ornithine decarboxylase activity during exercise and hypoxia. Res Commun Chem Pathol Pharmacol 1977 18: 67-74.
66. Warnica JW, Antony P, Gibson K, Harris P. The effect of isoprenaline and propranolol on rat myocardial ornithine decarboxylase. Cardiovasc Res 1975; 6: 793-6.
67. Cubría JC, Reguera R, Balaña-Fouce R, Ordóñez C, Ordóñez D. Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. J Pharm Pharmacol 1998; 50: 91-6.
68. Schlüter KD, Frischkopf K, Flesch M, Rosenkranz S, Taimor G, Piper HM. Central role for ornithine decarboxylase in betaadrenoceptor mediated hypertrophy. Cardiovasc Res 2000; 45: 410-7.
69. Moruzzi G, Caldarera CM, Casti A. The biological effect of polyamines on heart RNA and histone metabolism. Mol Cell Biochem 1974; 3: 153-61.
70. Gibson K, Harris P. The in vitro and in vivo effects of polyamines on cardiac protein biosynthesis. Cardiovasc Res 1974; 8: 668-73.
71. Bartolome JV, Trepanier PA, Chait EA, Slotkin TA. Role of polyamines in isoproterenol-induced cardiac hypertrophy: effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. J Mol Cell Cardiol 1982; 14: 461-6.
72. Tipnis UR, He GY, Li S, Campbell G, Boor PJ. Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis. Cardiovasc Pathol 2000; 9: 273-80.
73. Shantz LM, Giordano E. In: Wang JW, Casero RA, Eds. Polyamine cell signaling: Physiology, pharmacology and cancer research. Totowa: Humana Press, Inc. 2006: 123-37.
74. Shantz LM, Feith DJ, Pegg AE. Targeted overexpression of ornithine decarboxylase enhances b-adrenergic agonist-induced cardiac hypertrophy. Biochem J 2001; 358: 25-32.
75. Leinwand LA, Fishman MC, Eds. Proceedings of Molecular biology of the heart (B6), Keystone Symposia; Keystone, CO, USA Feb 13-18, 2002.
76. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
77. Barouch LA, Cappola TP, Harrison RW, et al. Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. J Mol Cell Cardiol 2003; 35: 637-44.
78. Lin Y, Wang LN, Xi YH, et al. L-arginine inhibits isoproterenolinduced cardiac hypertrophy through nitric oxide and polyamine pathways. Basic Clin Pharmacol Toxicol 2008; 103:124-30.
79. Ozaki M, Kawashima S, Yamashita T, et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 2002; 66: 851-6.
80. Bauer PM, Buga GM, Fukuto JM, Pegg AE, Ignarro LJ. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem 2001; 276: 34458-64.
81. Blachier F, Robert V, Selamnia M, Mayeur C, Duee PH. Sodium nitroprusside inhibits proliferation and putrescine synthesis in human colon carcinoma cells. FEBS Lett 1996; 396: 315-8.
82. Hu J, Mahmoud MI, el-Fakahany EE. Polyamines inhibit nitric oxide synthase in rat cerebellum. Neurosci Lett 1994; 175: 41-5.
83. Li H, Meininger CJ, Hawker JR Jr, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280: E75-82.
84. Giordano E, Shantz LM, Hillary RA, Guarnieri C, Caldarera CM, Pegg AE. In: Dhalla NS, Hryshko LV, Kardami E, Singal PK, Eds. Signal transduction and cardiac hypertrophy. Boston: Kluwer Academic Publishers 2003: pp. 49-56.